UNIVERSITÀ DI PISA CONFERENCE REGISTRATION € 375,00 + VAT 22% Registration fee includes: conference kit, admission to all the scientific sessions, lunch and coffee breaks. It is possible to register online on the Official Site: http://www.ipadcongress.com CONFERENCE VENUE SEPTEMBER 27, 2014 FIRENZE Grand Hotel Baglioni GRAND HOTEL BAGLIONI Piazza Unità Italiana, 6 - Firenze ITALIA www.hotelbaglioni.it OFFICIAL LANGUAGE English is the official language of the Conference. No simultaneous translation will be provided. CONTINUING MEDICAL EDUCATIONS ( CME ) Italian CME credits will be requested. Supported by unrestricted educational grants by Organizing Secretariat First Class S.r.l. Meetings and Conferences Viale Italia, 173 - 57127 Livorno - Via Malasoma, 14/16 - 56121 Pisa - Italy - Ph: +39 0586 84 98 11 - Email: [email protected] WEBSITE http://www.ipadcongress.com INTERNATIONAL CONFERENCE ON NEW THERAPIES FOR DEMENTIA AND PARKINSONIAN SYNDROMES FACULTY Giovanni Abbruzzese (Genova) Alberto Albanese (Milano) Alfredo Berardelli (Roma) Valentina Berti (Firenze) Ubaldo Bonuccelli (Viareggio) The 2nd International Conference on New Therapies for Dementia and Parkinsonian second edition after the first successful 2013 Conference in Pisa. The conference will bring together European experts of neurodegenerative diseases coming from the academic world, hospital centres and pharmaceutical industry. The Meeting will focus on the new possibilities of preclinical and early diagnosis, and Alberto Costa (Roma) on the more innovative pharmacological and non-pharmacological therapies. G. Di Chiara (Cagliari) The results of clinical trials will be evaluated and discussed, as well as on-going Antonio Federico (Siena) studies and the expected outcomes, drugs' pipeline, non-pharmacological Laura Fratiglioni (Stockholm) therapies, perspectives on biomarkers and on future diagnostic-therapeutic Jean-Charles Lambert (Lille, France) scenario and unmet needs of patients with dementia and parkinsonian syndromes. Niccolò Marchionni (Firenze) This highly condensed meeting will be repeated alternatively in Pisa and Florence Massimo Musicco (Roma) with the aim of becoming a reference mark on what's new in the field of therapies Nicola Origlia (Pisa) of neurodegenerative diseases. Francesco Saverio Pavone (Firenze) Sandro Sorbi - Ubaldo Bonuccelli Congress Presidents Leandro Provinciali (Ancona) Alberto Pupi (Firenze) Silvia Ramat (Firenze) Gabriele Siciliano (Pisa) Maria Grazia Spillantini (Cambridge, UK) Massimo Stefani (Firenze) Fabrizio Stocchi (Roma) Fabrizio Tagliavini (Milano) Gregor Wenning (Innsbruck, Austria) Opening: S. Sorbi, U. Bonuccelli 09:00 - 10:30 Risk factors: what's new Chairmen: A. Federico - L. Provinciali Dementia: from observation to intervention - L. Fratiglioni New frontiers in genetic studies - J. C. Lambert C9orf72 repeat expansions in dementia and extrapyramidal disorders - V. Silani Coffee break 11:00 - 13:00 Chairman: M. Musicco Entorhinal cortex as a model to study synaptic dysfunction in Alzheimer’s disease - N. Origlia Modelling Multiple System Atrophy: Update - G. Wenning Synaptic dysfunction in synucleinopathies - M.G. Spillantini Memory and Movement: the relationship between motor symptom lateralization and cognitive performance - A. Costa 13:00 - 14:00 Lunch Elio Scarpini (Milano) Sandro Sorbi (Firenze) 08:45 Syndromes (ICDP) will take place in Florence on September 27, 2014: this is the Giovanni Umberto Corsini (Pisa) Vincenzo Silani (Milano) Saturday September 27 International Conference on new Therapies for Dementia and Parkinsonian Syndromes LOCAL ORGANIZING COMMITTEE Laura Bracco (Firenze) Roberto Ceravolo (Pisa) Camilla Ferrari (Firenze) Gemma Lombardi (Firenze) Benedetta Nacmias (Firenze) Gloria Tognoni (Pisa) 14:00 - 14:30 Early diagnosis: neuroimaging biomarker Chairman: S. Sorbi Neuroimaging: new biomarkers for Alzheimer disease and Parkinson disease - A. Pupi / V. Berti 14:30 - 15:30 Pharmacotherapeutical Strategies Chairmen: G. Abbruzzese - G. Siciliano Dopamine receptors: therapy of Parkinson's disease - G. Di Chiara Therapy of rare dementias - F. Tagliavini 15:30 - 18:30 New trials and new drugs Emerging Therapeutical Strategies Chairmen: A. Berardelli - A. Albanese Clinical trials in dementia: problems and prospectives - E. Scarpini Clinical Trials in Parkinson's disease: problems and prospectives - F. Stocchi Coffee break Deep Brain Stimulation: a critical review - S. Ramat Oleuropein aglycone: a new possible long-term treatment to reduce risk of neurodegeneration and dementia in aged people - M. Stefani From nanoword to the macro through the micro F.S. Pavone General discussion